Bayer AG

Drugmaker Bayer Just Offered To Buy Monsanto For $62B

German pharmaceutical giant Bayer says acquiring U.S.-based Monsanto would create a "global agriculture leader."

By Lauren Stephenson | May 23, 2016

A German drug company has offered to buy U.S. agriculture company Monsanto for $62 billion.

Pharmaceutical giant Bayer announced the all-cash offer Monday. Monsanto sells seeds and herbicides.

Bayer calls itself a "life science company." Aside from making medications, it also sells seeds and pest control products to farmers.

Article Continues Below

If the deal goes through, it would create one of the largest agricultural suppliers in the world.

"We would combine complimentary skills with minimal geographic overlap. We at Bayer have a leading position in crop protection, and Monsanto is extremely strong in seeds and trades," said Bayer AG CEO Werner Baumann.

Monsanto is based in St. Louis and has a total of over 21,000 employees worldwide. More than 10,000 of those employees work in the U.S., according to its website.

Bayer employs about 117,000 people, and 16,000 of them work in the U.S. and Canada.

Bayer says if the deal goes through, the North American headquarters and global Seeds & Traits division would be based in St. Louis and the company would have "an important presence" in Durham, North Carolina, and many other locations in the U.S., including a digital farming home base near San Fransisco. Crop protection and divisional Crop Science headquarters would be in Germany.

This video includes clips from Bayer and images from BayerMonsanto and Getty Images.

Want to see more stories like this?
Like Newsy on Facebook for More Company News Coverage